NEJM: Early Combo Monoclonal Antibody Therapy in COVID-19
NEJM has published the interim analysis of the REGN-COV2 trial, wherein an antibody cocktail reduced viral loads with less clinical consequences.
Recent data suggest that high viral loads are associated with greater risk for COVID-19 complications and death. A combination of two
Read Article